Literature DB >> 12566956

The use of standardized incidence and prevalence rates in epidemiological studies on multiple sclerosis. A meta-analysis study.

Robert Zivadinov1, Leo Iona, Luisa Monti-Bragadin, Antonio Bosco, Ante Jurjevic, Cristina Taus, Giuseppe Cazzato, Marino Zorzon.   

Abstract

OBJECTIVE: To demonstrate whether or not the age and sex adjustment of incidence and prevalence rates in multiple sclerosis (MS) could allow more reliable comparison between epidemiological studies performed in different areas of the world and to establish if the latitude gradient theory could be confirmed after the standardization for age and sex distribution.
METHODS: A meta-analysis of population-based incidence and prevalence studies on MS from 1980 through 1998 using the terms 'multiple sclerosis', 'prevalence' and 'incidence' in the bibliographic databases MEDLINE and EMBASE was performed. We included studies that reported the diagnostic criteria, number of cases and the population studied, the date of the study, the latitude, and the age- and sex-specific crude incidence and prevalence rates. According to the inclusion criteria, 69 of 127 papers on prevalence and 22 of 70 papers on incidence were considered for age adjustment and 27 prevalence and 8 incidence studies for sex adjustment. The mean incidence and prevalencerates and the 95% confidence intervals age- and sex-adjusted to the World and the European standard populations were calculated.
RESULTS: The Spearman rank correlation and the multiple regression analyses indicated that age adjustment to standard populations could overcome the limitations in comparing the crude prevalence and incidence rates of different epidemiological studies on MS. When the mean crude and age- and sex-adjusted prevalence and age-adjusted incidence rates were stratified by latitude (from south to north), the latitudinal gradient, which was highly significant for the crude rates, became less remarkable for the age- and sex-adjusted prevalence rates and not significant for the age-adjusted incidence rates.
CONCLUSIONS: The crude incidence and prevalence rates in epidemiological studies on MS should be age- and sex-adjusted to a common standard population to permit a more reliable comparison among studies performed in different countries. Our findings support the opinion that the latitude does not play a key role in determining the onset of MS. Whenever possible, the crude incidence and prevalence rates should be adjusted to the ethnic origin and migration characteristics. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12566956     DOI: 10.1159/000067107

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  14 in total

1.  Shedding light on the link between early life sun exposure and risk of multiple sclerosis: results from the EnvIMS Study.

Authors:  Sandra Magalhaes; Maura Pugliatti; Trond Riise; Kjell-Morten Myhr; Antonio Ciampi; Kjetil Bjornevik; Christina Wolfson
Journal:  Int J Epidemiol       Date:  2019-08-01       Impact factor: 7.196

2.  Epidemiology of systemic lupus erythematosus: capturing the butterfly.

Authors:  S Sam Lim; Cristina Drenkard
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

3.  Incidence of multiple sclerosis in the United Kingdom : findings from a population-based cohort.

Authors:  A Alonso; S S Jick; M J Olek; M A Hernán
Journal:  J Neurol       Date:  2007-10-01       Impact factor: 4.849

Review 4.  The cost of multiple sclerosis and the cost effectiveness of disease-modifying agents in its treatment.

Authors:  Ceri J Phillips
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 5.  Temporal trends in the incidence of multiple sclerosis: a systematic review.

Authors:  Alvaro Alonso; Miguel A Hernán
Journal:  Neurology       Date:  2008-07-08       Impact factor: 9.910

6.  Increasing incidence of multiple sclerosis among women in Buenos Aires: a 22 year health maintenance organization based study.

Authors:  E Cristiano; L Patrucco; J Miguez; D Giunta; J Peroni; J I Rojas
Journal:  Neurol Sci       Date:  2016-06-23       Impact factor: 3.307

7.  Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.

Authors:  C McGuigan; A McCarthy; C Quigley; L Bannan; S A Hawkins; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-04       Impact factor: 10.154

8.  Incidence of multiple sclerosis in Northern Lisbon, Portugal: 1998-2007.

Authors:  Joao de Sá; Enrique Alcalde-Cabero; Javier Almazán-Isla; Fernando García-López; Jesús de Pedro-Cuesta
Journal:  BMC Neurol       Date:  2014-12-21       Impact factor: 2.474

Review 9.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Authors:  Elaine Kingwell; James J Marriott; Nathalie Jetté; Tamara Pringsheim; Naila Makhani; Sarah A Morrow; John D Fisk; Charity Evans; Sarah Gabrielle Béland; Sophie Kulaga; Jonathan Dykeman; Christina Wolfson; Marcus W Koch; Ruth Ann Marrie
Journal:  BMC Neurol       Date:  2013-09-26       Impact factor: 2.474

10.  The prevalence of multiple sclerosis in 3 US communities.

Authors:  Curtis W Noonan; Dhelia M Williamson; Judy P Henry; Robert Indian; Sharon G Lynch; John S Neuberger; Randolph Schiffer; Janine Trottier; Laurie Wagner; Ruth Ann Marrie
Journal:  Prev Chronic Dis       Date:  2009-12-15       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.